Acceligen successfully breeds gene-edited pigs with PRRS resistance

Feb 27, 2023

Acceligen, a leading innovator in sustainable agriculture, is proud to announce the breeding of gene-edited pigs with resistance to porcine reproductive and respiratory syndrome. This breakthrough represents a significant step forward in the pursuit for sustainable and ethical pork production.

PRRS is the most devastating disease to the swine industry in the United States, affecting not only the productivity of pigs, but also their health and wellness. This regularly occurring and complex disease has been documented to cause an estimated $500 million USD of losses to the pork producers, thus affecting the food security of countless people around the world.

Click here to see more...

Video: How Aurora Pharmaceutical Became a Leader in Animal Health

Dr. Michael Strobel, Founder and CEO of Aurora Pharmaceutical, discusses the company's remarkable journey from a veterinarian-led startup to a leading developer and manufacturer of animal health solutions.

In this exclusive interview, Dr. Strobel shares how Aurora Pharmaceutical was built around a simple but powerful mission: putting customers, producers, veterinarians, pet owners, and patients first. Learn how the company has grown by focusing on high-quality, science-backed, and cost-effective solutions for livestock, companion animals, and human health markets.

Discover how Aurora's commitment to innovation, affordability, and customer service continues to drive its expansion across swine, cattle, poultry, equine, companion animal, and human health sectors. Dr. Strobel also discusses the importance of understanding real-world challenges facing producers and veterinarians and how Aurora develops practical solutions that improve animal health while supporting producer profitability. Aurora's veterinarian-founded approach, commitment to American manufacturing, and focus on delivering value have helped establish the company as a trusted partner throughout the animal health industry.